Cystic Fibrosis
A newborn with meconium ileus must be evaluated for cystic fibrosis (CF). Meconium ileus is diagnostic of CF and occurs in approximately 15-20% of children with CF as their first clinical manifestation 1.
Why This Evaluation is Critical
Meconium ileus represents an intestinal obstruction present at birth caused by inspissated meconium, and because meconium ileus is diagnostic of CF, all infants presenting with this condition require immediate CF evaluation 1. The guideline evidence is unequivocal on this point—meconium ileus is considered pathognomonic for cystic fibrosis 2.
Specific Diagnostic Workup Required
When meconium ileus is identified (either prenatally, at birth, or in the immediate neonatal period), the following evaluations must be performed:
Confirmatory Testing
Sweat chloride test: This remains the gold standard diagnostic test. A sweat chloride level >60 mEq/L confirms CF, though infants may initially have values of 30-59 mEq/L 1. Testing can be performed accurately in most infants at 2-3 weeks of age 1.
CFTR genetic mutation analysis: All newborns with meconium ileus should undergo genetic testing to identify CFTR mutations. The most common mutations include F508del, G542X, W1282X, R553X, and G551D 3. In one series, all children operated on for meconium ileus had mutations in both alleles of the CFTR gene identified 4.
Important Clinical Context
The relationship between meconium ileus and CF is so strong that in every case of intra-operative diagnosis of meconium ileus, genetic testing and sweat tests are necessary to confirm or exclude CF 4, 5. Even in the absence of family history, CF must be considered 6.
Mortality and Morbidity Implications
This evaluation directly impacts mortality and quality of life outcomes:
- Children with meconium ileus have long-term adverse outcomes including malnutrition, lung disease, and mortality at rates comparable to those detected later through clinical symptoms 1
- Early CF diagnosis enables immediate initiation of pancreatic enzyme supplementation, high-fat diet, and aggressive pulmonary care
- Delayed diagnosis can result in life-threatening complications including bowel perforation, peritonitis, and decompensated shock 7
- Median survival for CF patients has increased to 33 years with appropriate early management 1
Common Pitfall to Avoid
Do not assume that a negative newborn screening result rules out CF in an infant with meconium ileus. Newborn screening can miss cases—children with meconium ileus may have low IRT values and be missed by screening but are detected soon after birth through clinical presentation 1. The clinical presentation of meconium ileus supersedes screening results and mandates direct diagnostic evaluation 5.